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THE EVALUATION OF HUMAN HISTOCOM-
PATIBILITY MATCHING in renal transplant 
recipients has not been possible with any-
thing like the precision of a controlled 
laboratory experiment. One reason has been 
that varying degrees of patient presensi-
tization may occur to antigens present in 
the eventual organ donor. The consequence 
of this unfavorable condition may be ac-
celerated or even hyperacute rejection in 
spite of an apparently good histocompatibil-
ity match. 
In recent years, increasing numbers of 
human renal homografts have been lost by 
hyperacute rejection. Although much has 
been learned about the complication, sev-
eral aspects of its pathogenesis have re-
mained unclear either because of seemingly 
contradictory reports in the clinical litera-
ture or because of insufficient experimental 
information about the interlocking roles of 
humoral antibodies, coagulation, and 
formed blood elements in the process of 
destruction. Consequently, this paper will 
attempt to clarify the existing state of 
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knowledge about hyperacute rejection by 
presenting a historical review of the sub-
ject and by describing several laboratory 
experiments designed to provide detailed 
data about the very earliest events of this 
form of graft destruction. 
HISTORICAL REVIEW 
The Role of Preformed Antibodies 
The first clear examples of hyperacute 
rejection of renal homografts were in pa-
tients who received kidneys from ABO 
blood group incompatible donors.l.2 An ef-
fective blood How to some of these trans-
plants was not restored when the vascular 
anastomoses were opened. The small vessels 
of the excised kidneys were demonstrated 
by angiography to be closed and, histo-
pathologically, the arterioles and capillaries 
were plugged with formed blood elements, 
particularly erythrocytes. A rational al-
though partial immunologic explanation 
was available since the blood group sub-
stances that allow red cells to be typed are 
also found in other tissues, including the 
kidneys.3.4 Consequently, if the kidney of 
an A, B, or AB donor were placed in a 
patient whose serum contained naturally 
occurring anti-A and/or anti-B isoag-
glutinins (an example would be a recipient 
with 0 blood type who would have both 
kinds of isoagglutinins), these antibodies 
might be predicted to bind with the renal 
red cell antigens. Serologic studies in some 
of our cases showed that falls in systemic 
isoagglutinin titers actually occurred.1 Sub-
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sequent authors have reached similar con-
clusions about the role of red cell isoag-
glutinins in precipitating accelerated 
rejections.5-7 
It is unlikely that future organ transplan-
tations will be carried out under the fore-
going adverse conditions of ABO mismatch-
ing. However, hyperacute rejection in the 
presence of red cell group compatibility 
has been seen with increasing frequency 
and, in fact, this kind of rejection has be-
come the chief cause of acute homograft 
loss in most major transplantation centers. 
The first case was described by Terasaki8 
in a patient whose serum contained lympho-
cytotoxic antibodies that killed donor cells. 
Terasaki speculated that, in the course of 
being transfused prior to operation, the 
recipient had been immunized to white 
cells that shared histocompatibility antigens 
with the eventual renal donor. Since then, 
no one has seriously challenged this general 
hypothesis of presensitization. The concept 
has been indirectly supported by the high 
rate of hyperacute rejection with retrans-
plantation in patients whose first homo-
grafts were rejected and who were thereby 
presumably immunized to some antigens 
also present in the second graft. 
Subsequently, Kissmeyer-Nielson and his 
associates9 and many other authors10-15 have 
confirmed the adverse implications of pre-
formed antidonor antibodies as detected 
with several techniques. The most com-
monly employed methods have measured 
lymphocytotoxins and leukoagglutinins, but 
the most sensitive examination has been 
said by Williams13 and MilgromI6,17 to be 
the mixed agglutination test. 
\Vhile certain tests may be more sensi-
tive than others for the detection of the 
preimmunized state, it does not seem likely 
that a single antibody will be found to 
have unique predictive significance. In our 
laboratories,18 deliberate sensitization of 
dogs by repeated skin grafts led to the 
formation of a variety of antibodies, each 
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with antidonor reactivity. As will be 
stressed again in the experimental portion 
of the present study, the titer of these anti-
bodies is not well correlated with the 
rapidity of rejection of a kidney from the 
skin donor. Moreover, it has been empha-
sized in reports of clinical casesll ,IU that 
hyperacute rejection, which is presumably 
due to presensitization, may occur even 
though anti donor antibodies cannot be 
found with any currently available tech-
nique including the mixed agglutination 
method. Under these latter circumstances 
it has been necessary to assumell ,19 that an 
immediate, albeit un discernible, immuno-
logic reaction is the initiating event in the 
destructive process that follows. 
As was speculated upon in an earlier pub-
lication,l1 it is conceivable that either an 
obvious or unobvious antigen-antibody 
union could occur within or outside the 
homograft. However, subsequent investiga-
tions from our laboratory18 and else-
where20,21 have suggested that the precipi-
tating immunologic events of hyperacute 
rejection probably occur almost always 
within the transplant. \Vith or without 
demonstrable antibodies in the recipient 
serum, the immunoglobulin deposition in 
the transplants may be in such small quan-
tities that their specificity as judged by 
strictly morphologic criteria in immuno-
fluorescence studies could be open to ques-
tionll,19 even though on other grounds it is 
reasonable to believe they are significant. 
Formed Blood Elements and Coagulation 
A simplistic view of hyperacute rejection 
might be that the anti donor antibodies dis-
cussed in the preceding section were de-
structive of renal homografts by their direct 
nephrotoxicity. The observations already 
cited in the ABO incompatible cases were 
not consistent with such a conclusion, since 
the most obvious lesion in the rapidly 
repudiated kidneys was occlusion of their 
blood supply by formed blood elements.1,2 
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In cases with red cell compatibility, there 
was also evidence of interference with the 
blood supply. When Kissmeyer-Nielson 
described the histopathology of two hyper-
acutely rejected kidneys,9 he noted that the 
glomerular capillaries and the arterioles 
were full of microthrombi making the mor-
phologic features indistinguishable from 
those of a generalized Shwartzman reaction. 
Similar observations were made in our own 
first cases.ll Although these histopathologic 
findings suggested that coagulation changes 
had occurred, clotting studies were not 
available to determine if the alterations 
were systemic or if they were confined to 
the actual homograft. The first efforts to 
obtain such information were completely 
negative.14,22 
More recently, evidence has been pub-
lished from our institution indicating that 
coagulation changes are an integral feature 
of hyperacute rejection in the presensitized 
canine modeP8 as well as in man.19 In the 
dogs that were exposed to multiple skin 
grafts from the eventual organ donor, the 
subsequently transplanted kidney, spleen, 
or liver always consumed clotting factors 
and platelets locally, One of the objectives 
of these animal investigations was to see if 
transplantation of consecutive organs from 
the same donor would mitigate the re-
jection of the second graft. It was found 
that the second transplant was briefly pro-
tected, possibly by the prior depletion of 
either humoral antibodies, clotting factors, 
or formed blood elements, In time, how-
ever, the final organ suffered the same fate 
as the first one, 
All of the sensitized canine recipients in 
the above study developed evidence of lo-
cal consumption. In addition, a minority 
of animals also had profound systemic co-
agulation changes that were like those of 
disseminated intravascular coagulation 
(DIe) .23,24 The same kinds of observations 
have been made in patients after renal 
homotransplantation with a consequent se-
vere or even fatal bleeding diathesis.19 
Thus, although the clotting aberrations of 
hyperacute rejection are usually confined 
to the graft insofar as can be measured, 
there is now little reason to doubt that 
profound systemic changes may follow. 
Formed Blood Elements 
White cells, platelets, and red cells form 
a morphologically prominent component of 
the vascular plugs in hyper acutely reject-
ing renal homografts. 'Williams et a1.l0 were 
the first to draw attention to the dramatic 
appearance of polymorphonuclear leuko-
cytes (PMN) in such kidneys. Their ob-
servations, since then amply confirmed,1l,15 
were made possible by systematically bi-
opsying homo grafts about I hr after revas-
cularization. In some instances the PMN 
appeared before any other histopathologic 
findings were evident. That the participa-
tion of these cells in the ultimate destruc-
tion was not immunologically specific was 
illustrated by the canine experiments of 
Clark25 and Robertshaw21 that showed that 
autologous PMN were effective intermedi-
aries of hyperacute rejection. 
MATERIALS AND METHODS 
Eight adult mongrel dogs were sensitized to 
specific donors with repeated transplantation (three 
to six times) of two skin fragments, one of which 
was placed orthotopically and the other was buried 
in the subcutaneous tissue. As the final step in 
sensitization, each of the eight dogs received the 
donor left kidney that was anastomosed to the 
common carotid artery and external jugular vein 
and removed after 2,4 hr. In one experiment, ad-
ditional immunization with splenic tissue was in-
terposed between the skin graft and renal graft 
phases. For this purpose, the donor spleen was 
removed, ground up, and forced through progres-
sively finer stainless steel meshes to a final size of 
denier 40. By this process 3.5 billion white cells 
were retrieved from the spleen as well as red cells 
and platelets too numerous to count. The cell sus-
pension, in nine parts saline and one part EDTA, 
was given to the recipient intravenously over 1 hr. 
For the definitive experiment the second donor 
kidney was revascularized onto the recipient right 
iliac vessels 1 wk after the first renal homotrans-
HOS 
plantation. A Teflon catheter was introduced into 
the right hypogastric vein and its tip positioned 
opposite the venous anastomosis. By temporarily 
clamping the common iliac vein below and above 
the anastomosis the total venous effiuent of the 
homograft could be collected. A plastic arterio-
venous shunt, from which arterial blood samples 
could be conveniently obtained, was inserted into 
the contralateral groin connecting the femoral 
artery and vein. Five additional control adult 
mongrel dogs received single renal homografts by 
the above described intra abdominal technique 
without prior sensitization. 
ImmutWlogic Studies 
Systemic venous blood samples were obtained 
before and during sensitization with skin and be-
fore and after transplantation of the first kidney. 
During the definitive renal homograft experiment, 
arterial samples were taken 5 min before and 15, 
30, 60, ami 120 min after revascularization of the 
kidney. In addition, renal venous samples were 
collected after 5, 15, 30, and 60 min so that arterio-
venous gradients across the organ could be meas-
meel. The blood was immediately chilled in an 
ice bath. Subsequently, the sera were analyzed 
for isohemagglutinins against donor red cells, anti-
donor leukoagglutinins,26 anti donor lymphocyto-
toxins determined in the presence of pooled male 
dog complement,27 and whole complement.28 
Hematologic and Coagulation Studies 
In six presensitized dogs, hematologic and 
coagulation studies were performed before and 
after transplantation of the definitive renal homo-
graft. Arterial samples were taken 5 min hefore 
and 15, 30, 60, 120, 240, and 360 min and (in 
three dogs) 24 hr after revascularization. Samples 
from the venous effiuent were obtained 1, 5, 15, 
30, 60, 120, and (in three dogs) 180 and 240 min 
after revascularization. The same samples were also 
collected in three nonsensitized control experiments. 
Hematocrit, white blood cell count, and 
platelets29 \verc determined in blood anticoagulated 
with EDTA. Plasma was obtained by mixing 9 
parts of blood with 1 part of anticoagulant (3 
parts 0.1 M sodium citrate, 2 parts 0.1 M citric 
acid) and centrifuging for 20 min at 4°C and 4000 
rpm. The following studies were done in fresh 
plasma: euglobulin lysis time,RO thrombin time with 
5 U/ml thrombin (Parke-Davis),31 prothrombin 
time with activated rabbit brain thromboplastin 
(Dade), and partial thromboplastin time.32 
Fibrinogen,;];l prothrombin (factor II) ,34 acceler-
ator globulin (factor V) ,35 antihemophilic globulin 
(factor VIII),36 plasma thromboplastin component 
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(factor IX) ,37 and plasminogen38 were assayed 
after storing the plasma at - 80°C. 
In two sensitized and two nonsensitized animals 
autologous fibrinogen labeled with 120139 and 
platelets labeled with 51Cr40 were injected 24 hr 
prior to transplantation. Arterial samples were ob-
tained serially before and after renal transplanta-
tion and assayed for quantitative platelet and 
fibrinogen levels as well as for radioactiVity. 
I mmutWfluorescence Studies 
Direct immunofluorescence41 was done on snap 
frozen renal biopsies from four first homografts 
placed in sensitized dogs 23-24 hr earlier and from 
17 biopsies taken from four second homo grafts 5 
min to 24 hr after transplantation. The native 
kidney, spleen, and liver 24 hr following renal 
transplantation were available from a single sen-
sitized dog. Seven serial biopsies from two control 
homo grafts placed in nonsensitized dogs were also 
studied. Fluorescein isothiocyanate-conjugated rab-
bit antisera shown to be speCific for dog IgG, C3, 
and fibrin by immunoelectrophoresis and double 
diffusion in agar were used. The immunofluores-
cence techniques and controls have been pre-
viously described in detai1.42 
RESULTS 
Rejection was considered complete when 
there was cessation of all venous return 
from the kidney transplant. In six of the 
Table I.-Titers of Preformed Antibodies in 
Recipients at Time of Definitive Renal 
Transplantation" 
Experiment Lymphocyto- Hemag- Leukoag- Rejection 
1y~llmber toxins glutinins glutinins (Hr) 
(Per Cent ( Titer) (Titer) 
Cells Killed) 
1 98 1:32 0 20 
2 46 1:8 1:8 5 
3 85 1:4 1:4 12 
4 80 0 1:4 24 
5 98 0 0 36 t 
6 80 1:4 1:2 4 
7 44 0 1:32 t 
8 98 1:4 0 36 
" The interval before rejection is also indicated. 
Time of rejection was determined when blood flow 
through the organ had ceased as judged by com-
plete absence of venous rehlm. 
t Complete rejection had not occurred when the 
homograft was removed 36 hr after revasculariza-
tion. 
t Dog died 4 hr after revascularization before 
rejection was completed. 
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Fig. I.-Homograft A-V gradient studies after renal homotransplantation to a dog 
sensitized to donor skin and kidney tissue. Arterial values are represented by solid lines; 
the venous results are shown in dashed lines, Note the gradients of clotting factors, anti-
bodies, platelets, and white cells. The apparent intrarenal concentration of red cells 
reflected by transient rise in hematocrit has been seen much more clearly after hetero-
b"ansplantation between divergent species. Complement units are CH50/ml. 
eight sensitization experiments, this con-
dition was met after 4-36 hr. The two other 
homo grafts still had a blood supply when 
the recipients died or were sacrificed after 
4 and 36 hr, respectively. The rejection 
times are given in Table 1. 
Immunologic Studies 
Prior to skin grafting, only one dog had 
isohemagglutinins against donor erythro-
cytes and none of the animals had natural 
leukoagglutinins or lymphocytotoxins. After 
sensitization, hemagglutinins as well as 
leukoagglutinins became detectable in five 
of the eight animals (Table 1). In addition, 
anti donor lymphocytotoxins eventually ap-
peared in every experiment. One reason for 
the invariability of the lymphocytotoxins 
was that their presence was required as 
evidence of the adequacy of sensitization. 
Following three to seven skin grafts, cyto-
toxins killed 24-98% (mean 65%) of donor 
lymphocytes. One week after transplanta-
tion of the first kidney, the lymphocyto-
toxins increased in four dogs, remained the 
same in three, and decreased in one, so 
that the killing power at the time of the 
definitive renal transplantation (Table 1) 
was 44-98% (mean 75%). 
There was no correlation between the 
titers of any of the antibodies and the 
rapidity of kidney rejection (Table 1). In 
six of the experiments, A-V gradients were 
obtained across the final renal graft. In 
one instance, there was evidence of marked 
absorption of lymphocytotoxins and com-
plement as well as less striking gradients 
of hemagglutinins and leukoagglutinins 
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Table 2.-Average Values and SE of Whole 
Complement (CH50) in Arterial and Renal 
Vein Blood Demonstrating the Maximum 
Arteriovenous Gradients 
CH50" 
Arterial Renal Vein AV 
Blood Blood Gradient 
Sensitized dogs t 33.3±5.6 24.6±3.6 9.8±2.3 
(6 animals) 
Nonsensitized dogs 38.5±3.0 32.3±2.4 6.2±O.9 
(3 animals) 
0) Fifty per cent hemolytic complement titer ex-
pressed in units.28 
t Compare the numbers of experiments with 
Table 1. 
(Fig. 1). Although this was the only un-
equivocal example of antibody absorption, 
depletion of complement was a significant 
finding in five of the six animals (Table 2). 
In the one experiment (No.5) in which 
complement uptake by the transplanted 
kidney was not found, the recipient's pre-
operative serum contained antidonor lym-
phocytotoxins which killed at a 98% 
efficiency, but no hemagglutinins or leuko-
agglutinins (Table 1). Virtually no change 
of the lymphocytotoxic activity in arterial 
blood was encountered after revasculariza-
tion of the graft and arteriovenous gradients 
were not present. Changes in formed blood 
elements and coagulation were not marked 
within this kidney and rejection was not 
completed even after 36 hI' when the organ 
was removed. 
Control studies were carried out in three 
nonsensitized recipients of canine renal 
homografts. Preformed hemagglutinins 
were found in two of the dogs (titers of 
1:4 and 1:8), but none of the animals had 
leukoagglutinins or lymphocytotoxins. Fol-
lowing transplantation of the kidney, the 
hem agglutinins were completely removed 
from the circulation in one of the dogs and 
unchanged in the other. In all three dogs 
there were A-V gradients of whole comple-
ment (mean maximum gradient 6.2 hemol-
ysin U) during the first 30-60 min (Table 
2). These complement gradients were con-
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siderably smaller than in the usual sensi-
tized canine recipient but the differences 
between the control and sensitization ex-
periments were not statistically significant. 
Coagulation and Hematologic Studies 
Between the arterial and venous blood 
of the renal homografts, there were striking 
gradients after transplantation to six sensi-
tized recipients. The changes indicated se-
questration within the transplants of plate-
lets, white cells and the five measured 
clotting factors (Table 3). In addition, 
there was profound shortening of euglobu-
lin lysis time (ELT) of the renal venous 
blood. The maximum gradients of all these 
determinations are summarized in Table 3. 
The decreases in clotting factors in the ve-
nous emuent blood were accompanied by 
slight prolongation of the thrombin and 
partial thromboplastin times. The pro-
thrombin time was not significantly altered. 
The kidneys which had the largest gradi-
ents tended to reject at the earliest times. 
With the evidence of consumption of the 
various substances within the organs, there 
were usually minor falls within the arterial 
blood. However, these were consonant with 
a local process and there were no examples 
of the disseminated intravascular clotting 
(DIe) which we have described in both 
animals18 and man.19 
In two of the six experiments described 
above, plasminogen levels in the arterial 
blood, 3-4 hI'S after transplantation of the 
definitive kidney, were decreased by 25 and 
28%. The homograft in one of these re-
cipients was completely rejected in 4 hI' 
after which the plasminogen promptly re-
turned to pretransplantation levels. In the 
other animal in which hyperacute rejection 
did not occur until one day, a 23-hr arterial 
sample had a 66% plasminogen reduction. 
A-V differences in the latter animal showed 
a gradient from 7.2 kc U in the arterial 
blood to 5.2 and 4.8 kc U in the venous 
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Table 3.-Average Values and SE of Fonned Blood Elements, Coagulation Factors, and Fibrinolysis 
in Arterial and Renal Vein Blood Demonstrating Maximum Arteriovenous Gradients 
in Sensitized and Nonsensitized Dogs 
Factor II Factor V Factor Factor IX Euglobulin 
Exp. Platelets White Cells Fibrinogen VIII Lysis Time ( cu mm) (mg/l00 ml) (Per Cent) (Per Cent) (Per Cent) Number lOS/cu mm (Per Cent) (min) 
Sensitized 
dogs 6 Artery 505±93 8771±1319 322±31 94±6.1 87±9.5 84±14.5 102±9.2 61 ±7.2 
Renal vein 123±39 3530± 761 242±26 79±4.3 74±7.8 6S±1O.S 83±2.9 17.5±3.1 
AV gradient 76 60 24 
(% fall 
from arterial 
value) 
Nonsensi-
tized dogs 3 Artery 251 7630 292 
Renal vein 237 6830 277 
AV gradient 7 11 
(% fall 
from arterial 
value) 
renal blood 1 and 5 min, respectively, after 
revascularization. 
The timing of the various alterations was 
fairly predictable (Fig. 1). Within 1 min, 
all the described changes had begun and in 
fact the maximum gradients of white cells, 
platelets, and EL T had already been ob-
served by this time. The maximum A-V 
difference of clotting factors were ordinarily 
reached somewhat later, after 1-5 min. By 
the end of 1 hr all detectable consumption 
had ceased in five of six experiments; in 
three of these five homografts the white 
blood COllnt of the venous blood eventually 
mli1. 
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exceeded that in the artery suggesting the 
escape of leukocytes from the transplant. 
Throughout the first 2 hr of multiple sam-
pling the average venous EL T remained 
shorter than that of the arterial blood (Fig. 
2) but this finding was significant only 
initially. Mter 24 hr, the arterial EL T be-
came greatly prolonged (Fig. 2) in the 
three experiments in which it was measured 
late. It should be noted that although none 
of the gradients persisted beyond 30-60 
min, the rejection did not develop until 
several hours later. 
The fates of labeled fibrinogen and plate-
lets were assessed in two special sensitiza-
tion experiments. One of the homografts 
(No.7, Table 1) was thought to have suf-
fered hyperacute rejection by 4 hr but the 
presence of a renal vein thrombosis in the 
excised kidney made the immunologic diag-
nosis less certain. No significant changes 
were found in either fibrinogen or platelets. 
The other transplant was rejected at 36 hr. 
In this experiment, transient and minor de-
creases of unlabeled fibrinogen and plate-
lets were observed early after transplanta-
tion. At eight hr the total platelet count was 
the same as prior to revascularization, 
whereas fibrinogen concentration had in-
creased about 20%. In contrast, there was 
a marked steady decline of the labeled 
1112 
populations of fibrinogen and thrombocytes 
so that 60 and 70%, respectively, had been 
lost within 8 hr. 
In three control renal homotransplanta-
tions, there was little or no consumption 
of platelets or clotting factors (Table 3). 
However, there was some sequestration of 
white blood cells, as well as shortening of 
the ELT in the renal venous blood (Table 
3), although both changes were less than 
in the presensitized recipients. The arterial 
plasminogen concentration was measured 
in one of the three dogs and did not change. 
Isotope studies in two additional control 
experiments did not reveal a significant 
change of platelet and fibrinogen half lives 
during the first hours after revasculariza-
tion of the kidneys. In one experiment, 
however, labeled fibrinogen decreased 60% 
and labeled platelets 63% during the first 
24 hr after transplantation. During this 
period, total fibrinogen remained un-
changed and total platelets decreased only 
10%. In our laboratory, the half lives of 
labeled platelets and fibrinogen are about 
2Jh) and 3 days, respectively. Consequent-
ly, the findings with the isotope studies 
suggested that platelets and fibrinogen 
were consumed abnormally rapidly even in 
the control animals, although the rate was 
considerably less than in the presensitized 
canine recipient described earlier. 
1II1mU11ofluorescence Studies 
The renal tissue from the first and second 
homografts in the sensitized dogs and the 
control homografts in the nonsensitized 
dogs contained minimal amounts of IgG 
throughout the tissue without any signifi-
cant anatomical concentration. Minimal 
amounts of C3 were also present as de-
scribed for IgG with additional small ir-
regular deposits of C3 seen predominantly 
in the vascular poles of the glomeruli in 
most of the kidneys studied. The presence 
of similar irregular C3 deposits had no 
immunologic specificity. No other C3 or 
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IgG was identified in the single native kid-
ney, spleen, or liver studied. 
The fibrin deposits identified in the renal 
homografts were quite different early fol-
lowing transplantation and at 24 hr when 
the kidney had been rejected. Early findings 
included fibrin in the glomeruli of the 
second transplants in an irregular pattern 
along the glomerular basement membrane 
as soon as 5 min following revasculariza-
tion. The extent of the fibrin deposits cor-
responded in a rough way to the rapidity 
of rejection, being slight in sensitized ex-
periment No.1, mild to moderate in Nos. 
2 and 3 (Fig. 3A), and moderate in No.6. 
The fibrin deposits in experiment Nos. 1 
and 6 remained unchanged during the pe-
riod of observation of 90-180 min, while in 
Nos. 2 and 3, the mild to moderate deposits 
present at 10 min decreased during the 
first hour (Fig. 3B). Only small amounts 
of fibrin were present in the peritubular 
capillaries of these kidneys. Small amounts 
of fibrin were present in the two control 
homo grafts placed in the nonsensitized dogs 
and did not change on serial observation 
over 60 to 120 min. The amount of fibrin in 
these kidneys was within or at the upper 
limits of that usually present in normal 
kidney tissue (Fig. 3C). No unusual peri-
tubular fibrin deposits were present. 
The five kidneys studied at 2.'3-24 hr 
following transplantation to sensitized re-
cipients (four first and 1 second homo-
grafts) contained variable fibrin deposits in 
the glomeruli with striking amounts of 
fibrin in the peritubular capillary areas of 
the kidney (Fig. 3D). No significant fibrin 
deposits were seen in the native kidney, 
spleen, or liver in one of the immunized 
animals. After one day, two homografts 
transplanted to nonsensitized recipients 
contained traces of fibrin in the glomeruli 
and peritubular capillaries. 
DISCUSSION 
By accurate measurement of arterio-
venous gradients across homografts, the 
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Fig, 3.-The patterns of renal fibrin deposition detected by fluorescein conjugated 
rabbit anticlog fibrin, (A) A glomerulus from sensitized dog 3 studied 10 min following 
vascularization of the second homograft. Moderate amounts of fibrin are present in an 
irregular pattern along the glomerular capillary walls (original magnification, x 400). 
(B) A glomerulus from the same kidney as in A, 60 min after vascularization. Most of 
tht' fibrin which was seen at 10 min has disappeared (original magnification, x 400). 
(C) A glomerulus (10 min) is shown from a homograft placed in nonsensitized control 
dog, A small amount of fine irregular fibrin is deposited along the glomerular capillary 
walls, This was the most extensive fibrin deposition seen in any of the control homografts 
(original magnification, x 400). (D) A glomerulus (arrows) and the surrounding renal 
tissue are shown from the first homograft (24 hr), placed in a sensitized dog. Moderate 
glomerular and heavy peritubular fibrin deposits are evident (original magnification, 
x 2.50). 
present study has provided furlher informa-
tion a bout the events of hyperacute renal 
rejection. In sensitized canine recipients, 
the transplanted kidney almost immediately 
became a trap for formed blood elements 
and clotting factors. Antibody absorption 
by the transplants also occurred although 
this was less clearly demonstrated than in 
an earlier study from our laboratories by 
Simpson et aPS Insofar as could be deter-
mined, the removal of these various sub-
stances occurred Simultaneously rather than 
in a well-spaced sequence. 
The inability to temporally dissect the 
component parts of hyperacute rejection or 
to demonstrate avid absorption of anti-
bodies cannot be taken as evidence against 
the initiation of the process by immunologic 
1114 
means. This has been the most important 
point of other experiments by ClarkI~d 
Robertshaw,21 and Simpson18 and their as-
sociates. Robertshaw21 briefly exposed ca-
nine homo grafts to the cell free or nearly 
cell free plasma of hyperimmunized recipi-
ents. When the organs were transplanted 
back to the original donors they were 
promptly destroyed, apparently with the 
participation of constituents of the autol-
ogous blood. 
In the animals of the present study, the 
speed of the hyperacute rejection seemed 
to be roughly related to the magnitude of 
extraction by the homograft of formed 
blood elements, and clotting factors. Never-
theless, the obvious signs of hyperacute 
rejection did not appear until several hours 
after the greatest A-V gradients had been 
recorded. Within a few minutes or even a 
few seconds after revascularization the ar-
teriovenous differences of platelets and 
clotting factors were maximal, but by 15 
min these gradients ordinarily had either 
become quite small or undetectable. Simi-
larly, leukocyte counts were now usually 
almost the same in arterial and venous 
samples and in at least three experiments, 
there was a reversed gradient with a much 
higher concentration of white cells in the 
renal venous blood. The same kind of ob-
servation, suggesting release of polymor-
phonuclear leukocytes (PMN) after initial 
entrappment, has been made before in 
manY) 
Because homograft blood flow was not 
continuously monitored in the experiments 
of the present report, it could be denied 
that the alterations in arteriovenous gradi-
ents represented true changes in clearance 
of the various substances. An alternative 
explanation might have been that the renal 
blood flow was very low in thc first few 
minutes with large A-V gradients and that 
flow later increased so the extraction re-
mained about the same. The technique used 
for venous sample collection helped to rule 
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out this possibility since it involved the 
transient capture of the total venous efflu-
ent. Using this method as a crude indicator 
of flow, large increases in the volume of 
venous return were not seen in the first 60 
min of the posttransplantation period. In-
stead, it seemed almost certain that kidneys 
transplanted into the hostile environment 
did in fact become quickly saturated, that 
the large early arteriovenous differences 
were indicative primarily of this fact rather 
than of major flow variations, and that later 
clearance of the same substances continued 
but at a rate that was too slow for easy 
detection. Under these circumstances, fail-
ure to obtain early samples could result in 
the kind of negative findings reported by 
Colman et a1.14 The isotope determinations 
of platelet and fibrinogen half-life in the 
present study were consistent with the in-
terpretation just described sincc an acceler-
ated consumption continued at least 
throughout the first posttransplantation 
day. With these techniques, the turnover 
of platelets and fibrinogen could be sep-
arated from repletion by synthesis or by 
mobilization of stores. 
The means by which an antigen-antibody 
reaction induces the clotting of hyperacute 
rejection is not known with certainty nor 
has the presumed collaborating role of 
PMN in this process been precisely defined. 
Possible functional interrelationships be-
tween immune reactions, formed blood ele-
ments, and coagulation have been dis-
cussed elsewhere19 and will not be repeated 
here beyond emphasizing again that the 
earliest evidence of clotting factor and 
platelet consumption seemed coincident 
with rather than pursuant to antibody fixa-
tion and PMN sequestration. Thus, if as 
seems likely, a sequential chain reaction 
were responsible in which the coagulation 
was the final event, the intermediary steps 
must have transpired almost instanteously. 
The production of the coagulation dis-
order was definitely dependent upon the 
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presensitized recipient state since essen-
tially no clotting changes at all could be 
detected when renal homotransplantation 
was carried out to unaltered dogs. In the 
latter control procedures the only abnor-
mality that could be detected was shorten-
ing of the EL T of the renal venous blood 
and even this change was less than that in 
the definitive experiments. It is probable 
that fibrinolysis in the controls was due to 
nonspecific injury in the course of the trans-
plantation. 
In the sensitization experiments of the 
present report, the clotting process was 
confined to the grafts and no examples were 
encountered of the systemic coagulopathy 
that we have described in dogs18 and in 
humans.19 However, in the event of a sys-
temic coagulopathy, it might also be en-
visioned that the clotting could be initiated 
in the kidney and then secondarily occur 
elsewhere. If this were true, the renal graft 
would be submitted to a primary injury as 
well as to a boomerang effect in which the 
fibrin strands from distant intravascular co-
agulation could circulate back and con-
tribute to further damage. 
\Vith an increased understanding of the 
pathogenesis of hyperacute rejection, it may 
become possible to evolve effective tech-
niques of therapy. Such developments have 
become increasingly needed as more and 
more potential recipients have become non-
candidates for transplantation by virtue of 
their prescnsitization. The most extreme 
example has proved to be the patient who 
has rejected a first or second homograft and 
who has developed antibodies against es-
sentially all members of the human popu-
lation. 
Two directions of inquiry would seem 
worthwhile pursuing. First, it may be use-
ful to interfere with the coagulation process 
as was speculated upon several years ago.n 
Recently, MacDonald and his associates·l~ 
pu blished evidence that this approach could 
be valuable under some circumstances. In 
hypersensitized dogs, they were regularly 
able to prevent immediate destruction of 
renal grafts by the simple expedient of 
prophylactic total body heparinization. 
Other means of interfering with the clotting 
process have not been systematically in-
vestigated under similar experimental con-
ditions. It is noteworthy that anticoagula-
tion had no effect whatever upon the 
hyperacute rejection that follows transplan-
tation of pig kidneys to canine recipients.44 
The logical alternative approach would 
be to eliminate the preformed antibodies, 
an undertaking which is not practical at 
present. That the principle may he sound 
is indicated by the prolongation of both 
homografts18 and heterografts44 that has 
been obtained by transplanting successive 
organs from the same donor. Presumably, 
the protection to the final graft was 
achieved by absorbing the antibodies on the 
first (or screening) organ. In addition, miti-
gation of heterograft rejection has been 
described after removal of immunoglobu-
lins by plasmapheresis.45 
SUMMARY 
Hyperacute rejection has been described 
on the basis of studies in human and canine 
recipients of renal homografts. This com-
plication ordinarily is a manifestation of a 
presensitized host state. The events of the 
abrupt homograft repudiation involve se-
questration by the transplanted organ of 
antibodies, platelets, white cells, and clot-
ting factors and consequent occlusion of 
the vessels of the graft. Although the fac-
tors contributory to hyperacute rejection 
have been well defined, the precise mech-
anism of the destructive process remains 
obscure. In particular, the pathogenetic in-
terrelationships of antibodies, formed blood 
elements, and clotting factors have not been 
well defined. 
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